Item 7.01 Regulation FD Disclosure.
Beginning on April 28, 2021, BioVie Inc. (the "Company") plans to make a series
of investor presentations (the "Investor Presentation") a copy of which is
attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated
herein by reference. The Company also expects to use the Investor Presentation
at the B. Riley Securities' Neuroscience Conference beginning on April 28, 2021
and from time to time thereafter in connection with presentations to potential
investors, industry analysts and others. The Investor Presentation is available
under the "Events and Presentations" tab in the "Investors" section of the
Company's website, located at www.biovie.com.
By filing this Current Report on Form 8-K and furnishing the information
contained herein, the Company makes no admission as to the materiality of any
information in this report that is required to be disclosed solely by reason of
Regulation FD.
The information contained in the Investor Presentation is summary information
that is intended to be considered in the context of the Company's Securities and
Exchange Commission ("SEC") filings and other public announcements that the
Company may make, by press release or otherwise, from time to time. The Company
undertakes no duty or obligation to publicly update or revise the information
contained in this report, although it may do so from time to time as its
management believes is warranted. Any such updating may be made through the
filing of other reports or documents with the SEC, through press releases or
through other public disclosure.
The information presented in Item 7.01 of this Current Report on Form 8-K and
Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities of that section, unless the Company specifically
states that the information is to be considered "filed" under the Exchange Act
or specifically incorporates it by reference into a filing under the Securities
Act of 1933, as amended, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number Description
99.1 Investor presentation dated April 28, 2021
© Edgar Online, source Glimpses